Bone Mass and Bone Mineral Metabolism at Diagnosis and After Intensive Treatment in Children With Acute Lymphoblastic Leukemia

Medical and Pediatric Oncology

Volumn 41, Issue 6, 2003, Pages 578-580

  Świa̧tkiewicz, Violetta ^a   Wysocki, Mariusz ^a   Odrowa̧z Sypniewska, Grazyna ^a   Koltan, Andrzej ^a   Manysiak, Slawomir ^a   Dylewska, Katarzyna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Acute lymphoblastic leukemia; Bone mineral density; Bone turnover markers

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HYPERCALCIURIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; CHILD; CHILD, PRESCHOOL; FEMALE; FRACTURES, BONE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; OSTEOPOROSIS; PROSPECTIVE STUDIES;

EID: 0242490561     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10415     Document Type: Article

References (9)

1. Arikoski P, Komulainen J, Riikonen P, et al. Impaired development of bone mineral density during chemotherapy: A prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res 1999;14:2002-2009.
2. Arikoski P, Komulainen J, Riikonen P, et al. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: A 1-year prospective study. J Clin Endocrinol Metab 1999;84:3174-3181.
3. Arikoski P, Kroger H, Riikonen P, et al. Disturbance in bone turnover in children with malignancy at completion of chemotherapy. Med Pediatr Oncol 1999;33:455-461.
4. Atkinson SA, Halton JM, Bradley C, et al. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs, and nutrition. Int J Cancer Suppl 1998;11:35-39.
5. Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 1996;11:1774-1783.
6. Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 2001;15:728-734.
7. Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: Pathogenesis and management. J Clin Oncol 2000;18:1570-1593.
8. Strauss AJ, Su JT, Kimball Dalton V, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001;19:3066-3072.
9. Świa̧tkiewicz V, Świa̧tkiewicz J, Kołtan A, et al. Assessment of bone mass of the forearm in children and adolescents population from Kujawsko-Pomorskie province by dual energy X-ray absorptiometry. Prz Pediatr 2001;3:208-211.